Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (491-500 of 549) with videos related to

Pageof 55
Sort By:
Leukemia|August 8, 2008
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistanceJ A McCubrey, S L Abrams, G Ligresti, et al.
Leukemia|May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemiaC Simioni, L M Neri, G Tabellini, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Oncotarget|September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeuticsCecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
American Heart Journal|November 22, 2001
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardiaL Padeletti, P Pieragnoli, C Ciapetti, et al.
Cells|March 10, 2022
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53Stephen L Abrams, Przemysław Duda, Shaw M Akula, et al.
Leukemia|March 26, 2011
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathwayA M Martelli, C Evangelisti, W Chappell, et al.
Leukemia|June 20, 2013
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic interventionJ A McCubrey, L S Steelman, F E Bertrand, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2011
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cellsLinda S Steelman, Patrick Navolanic, William H Chappell, et al.
Pageof 55

Showing results (491-500 of 549) with videos related to

Sort By:
Pageof 55
Leukemia|August 8, 2008
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistanceJ A McCubrey, S L Abrams, G Ligresti, et al.
Leukemia|May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemiaC Simioni, L M Neri, G Tabellini, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Oncotarget|September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeuticsCecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
American Heart Journal|November 22, 2001
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardiaL Padeletti, P Pieragnoli, C Ciapetti, et al.
Cells|March 10, 2022
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53Stephen L Abrams, Przemysław Duda, Shaw M Akula, et al.
Leukemia|March 26, 2011
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathwayA M Martelli, C Evangelisti, W Chappell, et al.
Leukemia|June 20, 2013
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic interventionJ A McCubrey, L S Steelman, F E Bertrand, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2011
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cellsLinda S Steelman, Patrick Navolanic, William H Chappell, et al.
Pageof 55